Skip to content

Atea Pharmaceuticals

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Roche and Atea announce AT-527 collaboration

    Roche and Atea Pharmaceuticals announced a collaboration to develop, manufacture, and distribute AT-527, an investigational oral antiviral being studied for COVID-19. Roche is responsible for distribution outside the United States; Atea is responsible for U.S. distribution, with an option to request Genentech’s support.